methotrexate has been researched along with Clerambault Syndrome in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, P; Bhakta, N; Brinkman, TM; Chemaitilly, W; Cheung, YT; Ehrhardt, MJ; Green, DM; Huang, IC; Hudson, MM; Hyun, G; Krull, KR; Liu, W; Mulrooney, DA; Ness, KK; Robison, LL; Srivastava, D; Williams, AM | 1 |
| Abdelkhalek, ER; Attia, EI; ElHaddad, A; Elsafy, ER; Hassan, TH; Kamal, NM; Raafat, N; Sanad, R; Shebl, A; Sherief, LM | 1 |
| Beaulieu, P; Bertout, L; Boulet-Craig, A; Drouin, S; Hudson, MM; Krajinovic, M; Krull, KR; Laniel, J; Laverdière, C; Lippé, S; Petrykey, K; Rezgui, A; Robaey, P; Sapkota, Y; Sinnett, D; St-Onge, P; Sultan, S; Yasui, Y | 1 |
| Cole, PD | 1 |
| Balzamo, M; Ceccaldi, M; de Roux-Serratrice, C; Disdier, P; Donnet, A; Félician, O; Gaudy, C; Granel, B; Manera, L; Pache, X; Raybaud, C; Serratrice, J; Swiader, L; Weiller, PJ | 1 |
| Rado, M; Terheggen, HG | 1 |
| Katz, ER; Rubenstein, CL; Varni, JW | 1 |
| Dinklage, D; Gioia, G; Paccia, J; Sallan, SE; Sherman, B; Sollee, N; Tarbell, NJ; Urion, DK; Waber, DP | 1 |
| Abel, EA; Kaplan, R; Lindae, ML; Luy, J | 1 |
1 review(s) available for methotrexate and Clerambault Syndrome
| Article | Year |
|---|---|
[Non-leukemic disease of the central nervous system in children with acute lymphoblastic leukemia. I. Somnolence syndrome (author's transl)].
Topics: Anorexia; Child; Disorders of Excessive Somnolence; Electroencephalography; Headache; Humans; Injections, Spinal; Leukemia, Lymphoid; Mental Disorders; Methotrexate; Myelin Proteins; Neurocognitive Disorders; Time Factors; Vomiting | 1978 |
8 other study(ies) available for methotrexate and Clerambault Syndrome
| Article | Year |
|---|---|
Childhood Neurotoxicity and Brain Resilience to Adverse Events during Adulthood.
Topics: Adult; Antimetabolites, Antineoplastic; Cancer Survivors; Cardiovascular Diseases; Chronic Disease; Cognitive Dysfunction; Cranial Irradiation; Endocrine System Diseases; Humans; Injections, Spinal; Logistic Models; Mental Status and Dementia Tests; Methotrexate; Nervous System Diseases; Neurocognitive Disorders; Neurosurgical Procedures; Neurotoxicity Syndromes; Odds Ratio; Radiation Injuries; Respiratory Tract Diseases | 2021 |
A Cross-sectional Study of Two Chemotherapy Protocols on Long Term Neurocognitive Functions in Egyptian Children Surviving Acute Lymphoblastic Leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cancer Survivors; Child; Child, Preschool; Cognition; Cross-Sectional Studies; Egypt; Female; Humans; Intelligence Tests; Male; Methotrexate; Neurocognitive Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Psychometrics; Treatment Outcome | 2018 |
Influence of genetic factors on long-term treatment related neurocognitive complications, and on anxiety and depression in survivors of childhood acute lymphoblastic leukemia: The Petale study.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adolescent; Adult; Antimetabolites, Antineoplastic; Anxiety; Calcium Channels, L-Type; Child; Child, Preschool; Cohort Studies; Depression; Female; Humans; Infant; Liver-Specific Organic Anion Transporter 1; Long-Term Care; Male; Methotrexate; Neurocognitive Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survivors; Young Adult | 2019 |
Does genetic susceptibility increase risk for neurocognitive decline among patients with acute lymphoblastic leukemia?
Topics: Economics, Pharmaceutical; Genetic Predisposition to Disease; Humans; Methotrexate; Neurocognitive Disorders; Oxidative Stress; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors | 2015 |
[Psychological and behavioral disorders with good outcome in neurosarcoidosis].
Topics: Adult; Antirheumatic Agents; Cognition Disorders; Drug Therapy, Combination; Facial Paralysis; Female; Humans; Hydroxychloroquine; Magnetic Resonance Imaging; Meningitis; Methotrexate; Nervous System Diseases; Neurocognitive Disorders; Paranoid Disorders; Prednisolone; Prognosis; Sarcoidosis; Treatment Outcome | 2001 |
Cognitive functioning in long-term survivors of childhood leukemia: a prospective analysis.
Topics: Adolescent; Brain; Child; Combined Modality Therapy; Cranial Irradiation; Education, Special; Female; Follow-Up Studies; Humans; Injections, Spinal; Intelligence; Learning Disabilities; Longitudinal Studies; Male; Methotrexate; Neurocognitive Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Radiation Injuries; Radiotherapy Dosage; Substance-Related Disorders; Wechsler Scales | 1990 |
Sex differences in cognitive processing in children treated with CNS prophylaxis for acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain; Child; Female; Follow-Up Studies; Humans; Injections, Spinal; Male; Methotrexate; Neurocognitive Disorders; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiation Injuries; Substance-Related Disorders | 1990 |
Mycosis fungoides with CNS involvement: neuropsychiatric manifestations and complications of treatment with intrathecal methotrexate and whole-brain irradiation.
Topics: Adult; Brain Neoplasms; Humans; Male; Methotrexate; Mycosis Fungoides; Neurocognitive Disorders; Radiotherapy; Skin Neoplasms | 1990 |